Northern Trust Corp Gossamer Bio, Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 410,116 shares of GOSS stock, worth $565,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

410,116

Previous 411,326 0.29%

Holding current value

$565,960

Previous $370,000 21.89%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.85 - $1.53 $1,028 - $1,851	-1,210 Reduced 0.29%	410,116 $451,000
Q4 2024 Feb 14, 2025	BUY	$0.66 - $1.07 $413 - $669	626 Added 0.15%	411,326 $370,000
Q3 2024 Nov 13, 2024	SELL	$0.79 - $1.25 $23,948 - $37,893	-30,315 Reduced 6.87%	410,700 $406,000
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $27,773 - $69,160	54,457 Added 14.09%	441,015 $396,000
Q1 2024 May 14, 2024	SELL	$0.8 - $1.51 $44,982 - $84,904	-56,228 Reduced 12.7%	386,558 $456,000
Q4 2023 Feb 13, 2024	BUY	$0.48 - $1.08 $2,892 - $6,508	6,026 Added 1.38%	442,786 $402,000
Q3 2023 Nov 13, 2023	BUY	$0.78 - $1.82 $187,508 - $437,518	240,395 Added 122.42%	436,760 $362,000
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.53 $404,219 - $631,077	-412,469 Reduced 67.75%	196,365 $235,000
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $48,818 - $148,490	-50,853 Reduced 7.71%	608,834 $767,000
Q4 2022 Feb 13, 2023	SELL	$1.74 - $12.87 $24,854 - $183,835	-14,284 Reduced 2.12%	659,687 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $338,120 - $697,812	46,896 Added 7.48%	673,971 $8.07 Million
Q2 2022 Aug 12, 2022	BUY	$5.97 - $9.97 $208,353 - $347,953	34,900 Added 5.89%	627,075 $5.25 Million
Q1 2022 May 13, 2022	SELL	$8.44 - $12.49 $49,914 - $73,865	-5,914 Reduced 0.99%	592,175 $5.14 Million
Q4 2021 Feb 08, 2022	SELL	$10.12 - $14.07 $23,761 - $33,036	-2,348 Reduced 0.39%	598,089 $6.76 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $56,325 - $102,783	-7,769 Reduced 1.28%	600,437 $7.55 Million
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $40,528 - $49,393	5,066 Added 0.84%	608,206 $4.94 Million
Q1 2021 May 12, 2021	SELL	$8.63 - $10.94 $446,999 - $566,648	-51,796 Reduced 7.91%	603,140 $5.58 Million
Q4 2020 Feb 11, 2021	SELL	$8.3 - $13.59 $187,687 - $307,310	-22,613 Reduced 3.34%	654,936 $6.33 Million
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $379,680 - $495,600	33,600 Added 5.22%	677,549 $8.41 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $1.19 Million - $1.99 Million	124,731 Added 24.02%	643,949 $8.37 Million
Q1 2020 May 14, 2020	SELL	$8.0 - $15.48 $3,776 - $7,306	-472 Reduced 0.09%	519,218 $5.27 Million
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $164,294 - $296,993	11,086 Added 2.18%	519,690 $8.12 Million
Q3 2019 Nov 13, 2019	BUY	$16.02 - $22.47 $5.27 Million - $7.39 Million	328,788 Added 182.85%	508,604 $8.54 Million
Q2 2019 Aug 13, 2019	BUY	$16.12 - $22.89 $263,400 - $374,022	16,340 Added 10.0%	179,816 $3.99 Million
Q1 2019 May 13, 2019	BUY	$17.58 - $23.97 $2.87 Million - $3.92 Million	163,476 New	163,476 $3.54 Million

Others Institutions Holding GOSS

# of Institutions

127

Shares Held

162M

Call Options Held

2.11M

Put Options Held

57.8K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $130M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Gossamer Bio, Inc. Transaction History